Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)

Status Completed

Clinical Trial Summary

Single-center, single-masked (the individual(s) performing efficacy and safety measures will be masked to treatment assignment for the patient(s) they are assessing), vehicle-controlled, randomized study.

Clinical Trial Description

Randomized study with 6 visits. For all dose groups a screening visit will be followed by a baseline visit 14 days later (qualification period). At the end of the qualification period patients who still exhibit signs of Meibomian Gland Dysfunction (MGD) at the baseline visit will be enrolled into a 3-month treatment period. At the baseline (Day 0) visit, patients will be randomly assigned to receive either AZR-MD-001 ointment/semi-solid drug or AZR-MD-001 vehicle twice-weekly. ;

Study Design

Related Conditions & MeSH terms

Meibomian Gland Dysfunction

Clinical Trial Details

NCT number	NCT04314362
Study type	Interventional
Source	Azura Ophthalmics
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	July 14, 2020
Completion date	January 6, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05062564` - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye	N/A
Completed	`NCT04884243` - Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction	Phase 2
Active, not recruiting	`NCT04425551` - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction	N/A
Terminated	`NCT02596919` - Fast Infrared Meibography (Photography)	N/A
Completed	`NCT01207752` - The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction	N/A
Completed	`NCT05162261` - to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction	N/A
Recruiting	`NCT06064071` - Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD	N/A
Completed	`NCT03652051` - A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)	Phase 2
Recruiting	`NCT03767530` - Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction	N/A
Active, not recruiting	`NCT05577910` - Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD	N/A
Completed	`NCT04889950` - Clinical Study to Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction	N/A
Recruiting	`NCT06004895` - Mechanisms of Light-based Therapies for Dry Eye Disease	N/A
Completed	`NCT04147962` - Intense Pulsed Light in Meibomian Gland Dysfunctions
Completed	`NCT02256969` - Intraductal Meibomian Gland Probing Trial	Phase 4
Recruiting	`NCT05089591` - Intense Pulsed Light in Meibomian Gland Dysfunction	N/A
Completed	`NCT04500821` - Evaluation of the LipiFlow System With a New Activator	N/A
Completed	`NCT03318874` - Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction	Phase 4
Completed	`NCT06278584` - iLux Treatment for Meibomian Gland Dysfunction	N/A
Recruiting	`NCT04052841` - Morphological Analysis of Meibomian Glands	N/A
Completed	`NCT05028491` - The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients